Search
For optimal search results, please limit to 2 product keywords
If you are searching for information related to a product:
- For optimal results, please enter at least 2 search terms in addition to product name
- Example: [product name] [search term] [search term]
- Example: Product + clinical trials
- For an exact match, please include search terms in double quotations. For example: "Elevatum"
Safety Data Sheets:
Product-Related Information
The information in this section may include content beyond what is in the FDA-approved label. Because the FDA has not approved such content, no conclusions regarding safety or efficacy may be made. Providing this information should not be construed as recommendation for use of a Genentech product for unapproved uses. For FDA-approved products please consult the product’s full prescribing information for a complete discussion of risks and benefits of the product(s) for its approved indication(s).
Publications and Congresses
The information in this section may include content beyond what is in the FDA-approved label. Because the FDA has not approved such content, no conclusions regarding safety or efficacy may be made. Providing this information should not be construed as recommendation for use of a Genentech product for unapproved uses. For FDA-approved products please consult the product’s full prescribing information for a complete discussion of risks and benefits of the product(s) for its approved indication(s).
Publications: The list of publications is not an exhaustive list of published materials on the product. The list of references by data topics is selected per evidence-based medicine criteria. To browse a full listing of published scientific literature:
Congresses: The list of congresses is a subset of Roche/Genentech posters and oral presentations for the product with data presented at scientific meetings in the recent 24 months. To browse full Roche/Genentech congress presentations and posters:
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
This material is being provided to you in accordance with the FDA Guidelines on Scientific Information on Unapproved Uses (SIUU)
- This clinical practice guideline contains information not contained within the approved product labeling for Genentech products, and therefore may contain information for which the safety and effectiveness has not yet been established.
- Reimbursement under public and private health care programs may not be available for unapproved product use. It is your responsibility to check applicable reimbursement policies before submitting claims for coverage.
- The opinions expressed in this clinical practice guideline do no necessarily reflect those of Genentech. Readers are encouraged to contact National Comprehensive Cancer Network® (NCCN®) with questions regarding the content of the clinical practice guidelines.
- You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch, or to Genentech at (888) 835-2555.
- Please see the full prescribing information for Venclexta (venetoclax) available at https://www.rxabbvie.com/pdf/venclexta.pdf for important safety and other information related to the approved use.
NCCN Guidelines® for Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
A free account is required to access the guidelines. The guidelines can be found under Guidelines>> Treatment by Cancer Type>> Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma